MassMutual Private Wealth & Trust
AXSM icon

MassMutual Private Wealth & Trust’s Axsome Therapeutics AXSM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.4K Sell
51
-2
-4% -$435 ﹤0.01% 1356
2026
Q2 		$13K Sell
53
-1
-2% -$217 ﹤0.01% 1284
2026
Q1 		$9.13K Buy
54
+2
+4% +$345 ﹤0.01% 1409
2025
Q4 		$9.5K Sell
52
-1
-2% -$140 ﹤0.01% 1413
2025
Q3 		$6.44K Sell
53
-53
-50% -$5.97K ﹤0.01% 1579
2025
Q2 		$11.1K Sell
106
-32
-23% -$3.39K ﹤0.01% 1320
2025
Q1 		$16.1K Buy
138
+132
+2,200% +$15K ﹤0.01% 1121
2024
Q4 		$508 Buy
+6
New +$552 ﹤0.01% 2139
2023
Q1 		– Sell
-4
Closed – – 1808
2022
Q4 		$0 Buy
+4
New +$239 ﹤0.01% 1642

Other funds holding AXSM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

MassMutual Private Wealth & Trust's AXSM Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Axsome Therapeutics (AXSM) stake by 3.8% in Q3 2026, selling an estimated $435 and leaving 51 shares worth $9.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

MassMutual Private Wealth & Trust first reported a position in AXSM in Q4 2022 and has held it in 9 quarters since. The position peaked at $16.1K in Q1 2025. 185 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • MassMutual Private Wealth & Trust held 51 shares of Axsome Therapeutics worth $9.4K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 2 Axsome Therapeutics shares in Q3 2026, an estimated $435.
  • Axsome Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1356 holding.
  • MassMutual Private Wealth & Trust first reported a position in Axsome Therapeutics in Q4 2022 and has held it in 9 quarters since.
  • MassMutual Private Wealth & Trust's Axsome Therapeutics position peaked at $16.1K in Q1 2025.
  • 185 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.